Literature DB >> 8735283

Cytochemical distribution of cyclic AMP-dependent 3',5'-nucleotide phosphodiesterase in the rat myocardium.

L Okruhlicová1, N Tribulová, A Eckly, C Lugnier, J Slezák.   

Abstract

The cytochemical localization of cAMP-dependent phosphodiesterase was studied in the rat myocardium. Slices 40 microns thick from perfusion-fixed rat hearts were incubated in the medium with cAMP as a substrate and Pb ions as a capture metal of the reaction product. After the incubation in the basic medium the specific precipitate of cAMP phosphodiesterase was localized on the sarcolemma of cardiomyocytes. In addition, it was localized on the plasmalemma of endothelial cells of capillaries and small coronary arteries as well as on the membrane of smooth muscle cells. Using selective inhibitors SK&F 94120 for phosphodiesterase III and Rolipram for the IV isoenzyme, both isoforms were detected on the membrane of smooth muscle cell. In addition, phosphodiesterase III was localized on the sarcolemma only and phosphodiesterase IV on the sarcolemma of cardiomyocytes and the plasmalemma of endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8735283     DOI: 10.1007/bf02331440

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  25 in total

Review 1.  Histo- and cytochemical demonstration of cyclic nucleotide phosphodiesterase activity in the rat outer retina.

Authors:  S Ueno
Journal:  Adv Second Messenger Phosphoprotein Res       Date:  1992

Review 2.  Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors.

Authors:  J A Beavo; D H Reifsnyder
Journal:  Trends Pharmacol Sci       Date:  1990-04       Impact factor: 14.819

3.  Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors.

Authors:  N Komas; C Lugnier; J C Stoclet
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

4.  [Changes in adenylate cyclase activity in the early phases of ischemia in cardiac myocytes].

Authors:  L Okruhlicová; J Slezák; N Tribulová; M Ficková
Journal:  Bratisl Lek Listy       Date:  1988-04       Impact factor: 1.278

Review 5.  Subcellular localization and biological function of specific cyclic nucleotide phosphodiesterases.

Authors:  V C Manganiello
Journal:  J Mol Cell Cardiol       Date:  1987-10       Impact factor: 5.000

6.  Characterization of indolidan- and rolipram-sensitive cyclic nucleotide phosphodiesterases in canine and human cardiac microsomal fractions.

Authors:  C Lugnier; B Muller; A Le Bec; C Beaudry; E Rousseau
Journal:  J Pharmacol Exp Ther       Date:  1993-06       Impact factor: 4.030

7.  Cytochemical localization of cyclic 3',5'-nucleotide phosphodiesterase activity in the rat olfactory mucosa.

Authors:  N Asanuma; H Nomura
Journal:  Histochem J       Date:  1993-05

8.  The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Implications for the mechanism of action of selective phosphodiesterase inhibitors.

Authors:  M L Reeves; B K Leigh; P J England
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

9.  Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells.

Authors:  J E Souness; B K Diocee; W Martin; S A Moodie
Journal:  Biochem J       Date:  1990-02-15       Impact factor: 3.857

10.  Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.

Authors:  A E Eckly; C Lugnier
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

View more
  6 in total

1.  Species differences in localization of cardiac cAMP-phosphodiesterase activity: a cytochemical study.

Authors:  L Okruhlicová; N Tribulová; J Styk; A Eckly; C Lugnier; J Slezk
Journal:  Mol Cell Biochem       Date:  1997-08       Impact factor: 3.396

2.  Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes.

Authors:  I Verde; G Vandecasteele; F Lezoualc'h; R Fischmeister
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

3.  Inotropy and L-type Ca2+ current, activated by beta1- and beta2-adrenoceptors, are differently controlled by phosphodiesterases 3 and 4 in rat heart.

Authors:  Torsten Christ; Alejandro Galindo-Tovar; Marcus Thoms; Ursula Ravens; Alberto J Kaumann
Journal:  Br J Pharmacol       Date:  2009-01       Impact factor: 8.739

4.  5-HT4-elicited positive inotropic response is mediated by cAMP and regulated by PDE3 in failing rat and human cardiac ventricles.

Authors:  F Afzal; K W Andressen; H K Mørk; J M Aronsen; I Sjaastad; C P Dahl; T Skomedal; F O Levy; J-B Osnes; E Qvigstad
Journal:  Br J Pharmacol       Date:  2008-09-01       Impact factor: 8.739

5.  Role of cyclic nucleotide phosphodiesterase isoforms in cAMP compartmentation following beta2-adrenergic stimulation of ICa,L in frog ventricular myocytes.

Authors:  Jonas Jurevicius; V Arvydas Skeberdis; Rodolphe Fischmeister
Journal:  J Physiol       Date:  2003-06-18       Impact factor: 5.182

6.  Short-term or long-term treatments with a phosphodiesterase-4 (PDE4) inhibitor result in opposing agonist-induced Ca(2+) responses in endothelial cells.

Authors:  M Campos-Toimil; T Keravis; F Orallo; K Takeda; C Lugnier
Journal:  Br J Pharmacol       Date:  2008-03-03       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.